Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 12 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (6)
P 2 (1)
P 4 (3)

Trial Status

Completed10
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (12)

Research Network

Activity Timeline